Targovax and Leidos will jointly explore the potential of combining their ONCOS and MicrotideTM technology platforms ONCOS will be used for intra-tumoral delivery of Microtide™ checkpoint inhibitor peptides Oslo, Norway 4 June 2020 – Targovax ASA (OSE: TRVX), a clinical stage immuno-... read more

Topline data expected by year-end 2020 Applications for US and EU regulatory approval planned for 2021   BOSTON, June 03, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer ther... read more

Oslo, Norway, 2 June 2020 Nordic Nanovector ASA (OSE: NANO) announces that members of its management team will present at Jefferies Virtual Healthcare Conference, taking place 2-4 June 2020. Nordic Nanovector will also present at ABG Sundal Collier Virtual Oncology Seminar 10 June 20... read more

PARIS, France June 1st, 2020, Vivet Therapeutics announced today that both the Food and Drug Administration (FDA) and the European Commission (EC) have granted Orphan Drug Designation (ODD) for Vivet’s second gene therapy product, VTX-803, for the treatment of Progressive Familial Intrahepatic Cho... read more

DUBLIN, Ireland and TREVOSE, Pa., June 01, 2020 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that ... read more